Claims
- 1. Process for the resolution of racemic 2-(o-chlorophenyl)-2-methylaminocyclohexanone of the formula: ##STR3## wherein * is an asymmetric carbon atom, which comprises the following steps:
- 1) reaction of racemic 2-(o-chlorophenyl)-2-methylaminocyclohexanone with an enantiomeric form of tartaric acid,
- 2) isolation of the formed tartaric acid salt of 2-(o-chlorophenyl)-2-methylaminocyclohexanone and
- 3) reaction of the isolated tartaric acid salt of 2-(o-chlorophenyl)-2-methylaminocyclohexanone with an alkali, whereby an isomer of 2-(o-chlorophenyl)-2-methylaminocyclohexanone can be isolated,
- wherein steps 1 and 2 are carried out in water or in a mixture of water and an alcohol and/or ketone, ether or ester.
- 2. Process according to claim 1, wherein the solvent in step 1 and step 2 is water or a mixture of water and isopropanol and/or acetone.
- 3. Process according to claim 1, wherein the solvent in step 1 and step 2 is water.
- 4. Process according to claim 1, wherein the solvent in step 1 and step 2 is a mixture of water and isopropanol.
- 5. Process according to claim 4, wherein the ratio of water:isopropanol is 1.5:1.
- 6. Process according to any of the preceding claims, wherein an aqueous solution of sodium hydroxide is used as alkali.
- 7. Process according to claim 1, wherein the free isomer obtained of 2-(o-chlorophenyl)-2-methylaminocyclohexanone is subsequently converted into the hydrochloride salt of the isomer in question by reaction with hydrochloric acid.
- 8. Process according to claim 1, wherein the ratio of water:acetone is in the range of 1:0.3-5.0.
- 9. Process according to claim 1, wherein the ratio of water:acetone is in the range of 1:3.
- 10. Process according to claim 1, wherein the ratio of water:acetone is in the range of 1:10-20.
- 11. Process according to claim 1, wherein the tartaric acid salt of 2-(o-chlorophenyl)-2-methylaminocyclohexanone isolated in step 2 is reacted directly in step 3 without subsequent recrystallisation.
- 12. Process according to claim 9, wherein the tartaric acid salt of 2-(o-chlorophenyl)-2-methylaminocyclohexanone isolated in step 2 is recrystallised before carrying out step 3.
Priority Claims (1)
Number |
Date |
Country |
Kind |
196 19 665 |
May 1996 |
DEX |
|
Parent Case Info
This application is a 371 of PCT/EP97/02360 filed May 7, 1997.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
102e Date |
371c Date |
PCT/EP97/02360 |
5/7/1997 |
|
|
11/10/1998 |
11/10/1998 |
Publishing Document |
Publishing Date |
Country |
Kind |
WO97/43244 |
11/20/1997 |
|
|
Foreign Referenced Citations (1)
Number |
Date |
Country |
2062620 |
Dec 1969 |
DEX |